Publications by authors named "Kainat Saleem"

Background: Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of extranodal B-cell lymphoma, which has traditionally been associated with poor outcomes. Despite increasing recognition, IVLBCL requires a high degree of clinical suspicion on the part of the clinician for its diagnosis.

Case Series: We present four patient cases: A 69-year-old female with constitutional symptoms and cognitive decline; a 78-year-old female with kidney injury and constitutional symptoms whose disease rapidly progressed to multiorgan failure and death; a 70-year-old asymptomatic female with an incidentally found, enlarged thyroid; and a 63-year-old male with cytopenia and constitutional symptoms.

View Article and Find Full Text PDF
Article Synopsis
  • Lenalidomide has been a standard treatment for multiple myeloma and related cancers for over ten years, but previous studies showed it might increase the risk of second primary malignancies (SPM).
  • A systematic review analyzed randomized controlled trials from various databases to assess SPM risk with lenalidomide, including 38 trials with 14,058 patients.
  • The meta-analysis found a slight overall increase in SPM risk (RR 1.16), but specifically for multiple myeloma, the risk was higher at 1.42, indicating variability across different cancer types.
View Article and Find Full Text PDF

Background And Objective: Melanoma is a disease notorious for the development of brain metastases, with consequently poor outcomes for patients who develop melanoma brain metastases (MBM). The treatment options for patients with MBM were limited to radiotherapy and surgery. MBM patients, particularly those with symptomatic disease, were excluded from clinical trials of immune checkpoint inhibitors (ICI) and BRAF/MEK inhibitors.

View Article and Find Full Text PDF

Purpose: Obesity has been associated with an increased risk of respiratory complications and other systemic illnesses. Respiratory dynamics in an obese patient, combined with modified lung physiology of ARDS, present a significant challenge in managing obese patients with ARDS. Many physicians think of obesity as a relative contraindication to ECMO.

View Article and Find Full Text PDF